fig. 1 —
JOINN Biologics Endorsed
13th Annual Bioprocessing Summit
Dr. Kevin Han, Director, Process Development-Upstream will be presenting a poster on “ATF N-1/N Stage Perfusion Platform Process Development Using mAb Producing CHO Cell Culture”
Perfusion cell culture processes have become more viable and easier to implement since they were introduced to biopharmaceutical manufacturing decades ago. One of these improvements, Alternating Tangential Flow (ATF), is being implemented in manufacturing processes.
Please join us for this informational poster talk at Bioprocessing Summit, August 16-19, 2021.
You can find JOINN Biologics at this year’s summit at Booth #425, at Sheraton Boston.